ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 210 filers reported holding ARGENX SE in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $589,956 | -88.8% | 1,200 | -91.5% | 0.02% | -89.5% |
| Q1 2023 | $5,290,636 | +145.7% | 14,200 | +149.8% | 0.22% | +93.0% |
| Q4 2022 | $2,153,270 | +366.1% | 5,684 | +334.2% | 0.11% | +533.3% |
| Q3 2022 | $462,000 | -91.0% | 1,309 | -90.3% | 0.02% | -91.9% |
| Q2 2022 | $5,115,000 | +1726.8% | 13,500 | +1587.5% | 0.22% | +1127.8% |
| Q4 2021 | $280,000 | -71.2% | 800 | -78.4% | 0.02% | -90.8% |
| Q3 2020 | $971,000 | – | 3,700 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 273,343 | $106,529,967 | 17.42% |
| Kynam Capital Management, LP | 184,300 | $71,827,239 | 9.88% |
| Ikarian Capital, LLC | 132,100 | $51,483,333 | 8.20% |
| Avoro Capital Advisors LLC | 1,263,500 | $492,423,855 | 6.68% |
| Artia Global Partners LP | 46,438 | $18,098,282 | 6.24% |
| DCF Advisers, LLC | 25,700 | $10,016,061 | 5.29% |
| Bellevue Group AG | 923,284 | $359,831,473 | 5.13% |
| Eagle Health Investments LP | 64,400 | $25,098,612 | 4.69% |
| Paradigm Biocapital Advisors LP | 150,000 | $58,459,500 | 4.52% |
| Paradigm Biocapital Advisors LP | 142,259 | $55,442,600 | 4.28% |